These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7543503)
21. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808 [TBL] [Abstract][Full Text] [Related]
22. Loss of size-selectivity at histamine-induced exudation of plasma proteins in atopic nasal airways. Greiff L; Andersson M; Erjefält JS; Svensson C; Persson CG Clin Physiol Funct Imaging; 2002 Jan; 22(1):28-31. PubMed ID: 12003096 [TBL] [Abstract][Full Text] [Related]
23. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity. Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995 [TBL] [Abstract][Full Text] [Related]
24. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Rasp G; Hochstrasser K Allergy; 1993 Feb; 48(2):72-4. PubMed ID: 8457035 [TBL] [Abstract][Full Text] [Related]
25. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Djukanović R; Feather I; Gratziou C; Walls A; Peroni D; Bradding P; Judd M; Howarth PH; Holgate ST Thorax; 1996 Jun; 51(6):575-81. PubMed ID: 8693436 [TBL] [Abstract][Full Text] [Related]
26. Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge. Zweiman B; Getsy J; Kalenian M; Lane A; Schwartz LB; Doty R; Lanza D J Allergy Clin Immunol; 1997 Nov; 100(5):624-31. PubMed ID: 9389292 [TBL] [Abstract][Full Text] [Related]
27. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322 [TBL] [Abstract][Full Text] [Related]
28. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338 [TBL] [Abstract][Full Text] [Related]
29. [Humoral mucosal immunity in allergic rhinitis]. Kramer MF; Jordan TR; Pfrogner E; Rasp G Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632 [TBL] [Abstract][Full Text] [Related]
30. Effects of fexofenadine on the early response to nasal allergen challenge. Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223 [TBL] [Abstract][Full Text] [Related]
31. Metachromatic, IgE-bearing and tryptase-containing cells on the nasal mucosal surface in provoked allergic rhinitis. Juliusson S; Karlsson G; Bachert C; Enerbäck L APMIS; 1994 Feb; 102(2):153-60. PubMed ID: 8167011 [TBL] [Abstract][Full Text] [Related]
32. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. Klimek L; Wolf H; Mewes T; Dormann D; Reske-Kunz A; Schnitker J; Mann W J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):47-53. PubMed ID: 9893184 [TBL] [Abstract][Full Text] [Related]
33. An in vitro model for measuring tryptase release from nasal mucosa in response to allergen challenge. Mason JD; Smith SJ; Jones NS; Majumdar B; Read RC Clin Otolaryngol Allied Sci; 1994 Oct; 19(5):407-9. PubMed ID: 7834882 [TBL] [Abstract][Full Text] [Related]
34. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo. Greiff L; Andersson M; Wollmer P; Persson CG Eur Respir J; 2003 Feb; 21(2):308-12. PubMed ID: 12608446 [TBL] [Abstract][Full Text] [Related]
35. Immunotherapy and mast cell activation. Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195 [TBL] [Abstract][Full Text] [Related]
36. Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect. Bernardini R; Novembre E; Mugnaini L; Rossi ME; Vierucci A Allergy Asthma Proc; 1998; 19(2):75-80. PubMed ID: 9578915 [TBL] [Abstract][Full Text] [Related]
37. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Clark JM; Abraham WM; Fishman CE; Forteza R; Ahmed A; Cortes A; Warne RL; Moore WR; Tanaka RD Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2076-83. PubMed ID: 8520778 [TBL] [Abstract][Full Text] [Related]
38. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Bradding P; Mediwake R; Feather IH; Madden J; Church MK; Holgate ST; Howarth PH Clin Exp Allergy; 1995 May; 25(5):406-15. PubMed ID: 7553243 [TBL] [Abstract][Full Text] [Related]
39. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306 [TBL] [Abstract][Full Text] [Related]
40. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Wang D; Clement P; Smitz J; De Waele M; Derde MP Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]